Sandra Abdellatef Selected Research

HuArgI (Co)-PEG5000

1/2021

Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Abdellatef Research Topics

Disease

2	Neoplasms (Cancer) 01/2021 - 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Hypoxia (Hypoxemia) 11/2019
1	Glioblastoma (Glioblastoma Multiforme) 11/2019

Drug/Important Bio-Agent (IBA)

2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2020 - 11/2019
1	Amino Acids FDA Link 01/2021
1	HuArgI (Co)-PEG5000IBA 01/2021
1	ArginaseIBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2020
1	GTP Phosphohydrolases (GTPases)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 11/2019
1	Epidermal Growth Factor (EGF)IBA 11/2019